EP1386153A2 - Oxazolidinon-photoaffinity sonden, verwendung und verbindung - Google Patents

Oxazolidinon-photoaffinity sonden, verwendung und verbindung

Info

Publication number
EP1386153A2
EP1386153A2 EP01993282A EP01993282A EP1386153A2 EP 1386153 A2 EP1386153 A2 EP 1386153A2 EP 01993282 A EP01993282 A EP 01993282A EP 01993282 A EP01993282 A EP 01993282A EP 1386153 A2 EP1386153 A2 EP 1386153A2
Authority
EP
European Patent Office
Prior art keywords
probe
biological target
methyl
oxo
photoaffinity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01993282A
Other languages
English (en)
French (fr)
Inventor
Gerard R. Colca
William Gerald Mcdonald
Dean L. Shinabarger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co LLC
Original Assignee
Pharmacia and Upjohn Co
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co, Upjohn Co filed Critical Pharmacia and Upjohn Co
Publication of EP1386153A2 publication Critical patent/EP1386153A2/de
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9446—Antibacterials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP01993282A 2000-12-15 2001-12-14 Oxazolidinon-photoaffinity sonden, verwendung und verbindung Withdrawn EP1386153A2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25605300P 2000-12-15 2000-12-15
US256053P 2000-12-15
PCT/US2001/048455 WO2002056013A2 (en) 2000-12-15 2001-12-14 Oxazolidinone photoaffinity probes, uses and compounds

Publications (1)

Publication Number Publication Date
EP1386153A2 true EP1386153A2 (de) 2004-02-04

Family

ID=22970924

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01993282A Withdrawn EP1386153A2 (de) 2000-12-15 2001-12-14 Oxazolidinon-photoaffinity sonden, verwendung und verbindung

Country Status (5)

Country Link
EP (1) EP1386153A2 (de)
JP (1) JP2004537265A (de)
AU (1) AU2002245127A1 (de)
CA (1) CA2432162A1 (de)
WO (1) WO2002056013A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7022705B2 (en) 2001-10-25 2006-04-04 Astrazeneca Ab Isoxazoline derivatives useful as antimicrobials
EP1892530A1 (de) * 2006-08-25 2008-02-27 Boehringer Ingelheim Pharma GmbH & Co. KG Verfahren zur Bestimmung der Transportaktivität eines Transportproteins
WO2008046584A2 (en) * 2006-10-16 2008-04-24 Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften Lepa as a target for antibacterial agents
US20230357266A1 (en) * 2022-05-04 2023-11-09 Promega Corporation Photoactivatable compounds and uses thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002048139A2 (en) * 2000-12-15 2002-06-20 Pharmacia & Upjohn Company Oxazolidinone photoaffinity probes

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002048139A2 (en) * 2000-12-15 2002-06-20 Pharmacia & Upjohn Company Oxazolidinone photoaffinity probes

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO02056013A3 *

Also Published As

Publication number Publication date
WO2002056013A2 (en) 2002-07-18
WO2002056013A3 (en) 2003-11-06
JP2004537265A (ja) 2004-12-16
CA2432162A1 (en) 2002-07-18
AU2002245127A1 (en) 2002-07-24

Similar Documents

Publication Publication Date Title
JP5733760B2 (ja) 蛍光発生分子および標的核酸検出方法
CN111675667A (zh) 一种异噁唑啉类驱虫药的制备方法
Masoud et al. Design, synthesis and biological evaluation of novel HIF1α inhibitors
US6031094A (en) Beta-lactam substrates and uses thereof
EP1386153A2 (de) Oxazolidinon-photoaffinity sonden, verwendung und verbindung
Chaparian et al. Hierarchical transcriptional control of the LuxR quorum-sensing Regulon of Vibrio harveyi
CN117720555A (zh) 一种制备kras抑制剂化合物的中间体及其合成方法
Kuboyama et al. Stoichiometry-focused 18F-labeling of alkyne-substituted oligodeoxynucleotides using azido ([18F] fluoromethyl) benzenes by Cu-catalyzed Huisgen reaction
Vo et al. Design of multimodal small molecules targeting miRNAs biogenesis: synthesis and in vitro evaluation
US20150321164A1 (en) Method for synthesizing and screening lead compound and reagent testing kit
CN104910894B (zh) 一种苯并咪唑类hERG钾离子通道的小分子荧光探针及其制备方法与应用
US6861433B2 (en) Oxazolidinone photoaffinity probes
JP2009014369A (ja) 生体分子標識用蛍光試薬
CN102516141B (zh) 五羟色胺转运体显像剂[18f]-fpbm的标记方法
Park et al. Role of the C (5)− C (5a) Exomethylene Group in Bicyclomycin: Synthesis, Structure, and Biochemical and Biological Properties
CN111170895B (zh) 一种2-羟基胍类化合物及其制备方法
JP4011937B2 (ja) ミスマッチ検出分子
Venkatachalam et al. Challenges in the automated synthesis of [18F]-1-fluoroethyl tryptophan: Formation of both O-and N-alkylated products
JP2002535680A (ja) 延長因子ｐ活性モジュレーターのアッセイ方法
CA2534047A1 (en) Oxazoles derivatives, their manufacture and their use as tyrosine kinase inhibitors
CN103183631B (zh) 靛红-5-磺酰胺类衍生物及其在制备治疗非典型性肺炎的药物中的应用
TWI373468B (en) Method for preparation of amido pyrazole
Singh et al. Synthesis, Antitubercular Activity, Molecular Modeling and Docking Studies of Novel Thiazolidin-4-One Linked Dinitrobenzamide Derivatives
Swain et al. Identification and optimisation of 5-amino-7-aryldihydro-1, 4-diazepines as 5-HT2A ligands
Seo et al. Development of PRPK Directed Phthalimides

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030625

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: PHARMACIA & UPJOHN COMPANY LLC

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: PHARMACIA & UPJOHN COMPANY LLC

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20060930